Objective: Clinical factors contributing to benzodiazepine failure in treating status epilepticus (SE) include suboptimal dosing and seizure duration. As many benzodiazepine-refractory episodes of SE arise from acute etiologies, we sought to determine whether etiology impacts SE treatment. Methods: The potency of diazepam to terminate SE induced by lithium-pilocarpine (LiPilo-SE) or kainic acid (KA-SE) in 3-week-old rats was studied by video-electroencephalography. Synaptic c-aminobutyric acid type A receptor (GABAR)-mediated currents were recorded from dentate granule cells using voltage-clamp electrophysiology. Surface expression of c2 subunit-containing GABARs and Kv4.2 potassium channels in hippocampal slices was determined using a biotinylation assay. Expression of phosphorylated forms of b2/3 and c2 subunits was determined using phosphospecific antibodies and Western blotting. Results: Diazepam failed to terminate late SE in LiPilo-SE animals but was successful in terminating KA-SE of 1-and 3-hour duration. One hour after SE onset, GABAR-mediated synaptic inhibition and c2 subunit-containing GABAR surface expression were reduced in LiPilo-SE animals. These were unchanged in KA-SE animals at 1 and 3 hours. Phosphorylation of c2 subunit residue S327 was unchanged in both models, although GABAR b3 subunit S408/409 residues were dephosphorylated in the LiPilo-SE animals. Kv4.2 potassium channel surface expression was increased in LiPilo-SE animals but reduced in KA-SE animals.
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Interpretation: SE-model-dependent differences support a novel hypothesis that the development of benzodiazepine pharmacoresistance may be etiologically predetermined. Further studies are required to investigate the mechanisms that underlie such etiological differences during SE and whether etiology-dependent protocols for the treatment of SE need to be developed. ANN NEUROL 2018; 83:830-841 P rompt treatment of status epilepticus (SE) is required to reduce the risk of cerebral injury and subsequent morbidity and mortality associated with these selfsustaining, prolonged seizures. Treatment of this neurological emergency frequently commences with a benzodiazepine, a c-aminobutyric acid type A receptor (GABAR) allosteric modulator, as this class of drugs has proved to be effective in treating SE in the out-of-hospital and in-hospital settings. [1] [2] [3] However, treatment with a benzodiazepine can fail. 3 Clinical factors contributing to benzodiazepine pharmacoresistance include suboptimal dosing, seizure duration, and potentially etiology, as many refractory SE cases are the result of acute symptomatic etiologies such as acute head injury, acute stroke, or one of the encephalitides. [4] [5] [6] [7] Benzodiazepine pharmacoresistance occurs in animal models in which SE was induced using the muscarinic agonist pilocarpine following a priming dose of lithium. 8, 9 Subsequent studies using this model demonstrated that the decline in potency of the benzodiazepines as a function of seizure duration may, in part, have resulted from subunit-specific, activity-dependent trafficking of the postsynaptic GABAR population, [10] [11] [12] [13] which led to a decrease in the surface expression of the benzodiazepine-sensitive c2 subunit-containing GABARs. This reduced surface expression correlated with a decline in the postsynaptic GABA-mediated chloride current. Once this postsynaptic response to GABA declined, the benzodiazepine dose that effectively terminated early SE failed to effectively increase GABA-mediated inhibition. 8, 12 As a result, the effective benzodiazepine concentration shifts such that higher doses, often in the anesthetic range, are required to terminate SE. Several animal models are available to study SE pathogenesis. Prolonged seizures lasting several hours can be induced not only by pilocarpine (SE induced by pilocarpine [Pilo-SE]) in isolation or in combination with lithium (SE induced by lithium-pilocarpine [LiPilo-SE]) but also using organophosphates such as di-isopropyl fluorophosphate, a glutamate receptor agonist such as kainic acid (SE induced by kainic acid [KA-SE]), electrical stimulation, and hyperthermia. Preclinical studies demonstrating dynamic changes in the surface expression of the GABARs have been limited to Pilo-SE and LiPilo-SE. 10, 12, 13 In one study, 10 GABA-mediated synaptic inhibition was reduced in acute hippocampal slices obtained from animals in which SE was induced by continuous hippocampal stimulation, but the GABAR surface expression was not evaluated. 10 Therefore, it is not known whether a change in the GABAR surface expression occurs in all episodes of SE or is conditional on etiology. Not all episodes of SE develop benzodiazepine pharmacoresistance. 3 Etiological dependence of GABAR trafficking during SE could be one potential mechanism to explain why some episodes of SE become refractory to benzodiazepines, whereas other prolonged episodes may continue to respond to a single dose of benzodiazepines. In this study, the etiological influence on benzodiazepine pharmacoresistance, synaptic inhibition, and GABAR subunit expression was compared in the LiPilo and KA models of SE.
Materials and Methods

Animals
Male Sprague-Dawley rats (23-25 days old) were used according to guidelines approved by the Animal Care and Use Committee of the University of Virginia. Rats were housed in Plexiglas cages with free access to food and water and kept on a regular day/night cycle.
Induction of SE and Electroencephalographic Analysis
SE was induced by administration of lithium (3mEq) followed 6 to 18 hours later by pilocarpine (50mg/kg, intraperitoneal [ip]) or by administration of KA (8mg/kg, ip). Animals were monitored for seizures behaviorally and electrographically using video-electroencephalographic (EEG) recordings. 11 For treatment studies, continuous spiking > 2Hz and amplitude > 2 times the background were considered to indicate the start of SE. For biochemical and electrophysiological studies, the time was calculated from the first observed stage V behavioral seizure on the Racine scale. 14 Power analysis was performed using house-written software in LabChart7 Pro (ADInstruments, Colorado Springs, CO) as described previously.
11,15
Biochemical Studies
Surface expression of c2 subunits was determined in hippocampi using a previously described biotinylation assay. 10, 11 The antibodies used in these studies were anti-c2 subunit antibody (clone 10F10-C1-B8, 2-3 lg/ml), 11 anti-b3 subunit antibody
(1:500; Novus Biologicals, Littleton, CO), anti-Kv4.2 (1:500; EMD Millipore, Billerica, MA), and anti-b-actin antibody (1:1,000; Sigma-Aldrich, St Louis, MO). The expression of phosphorylated c2 and b3 subunits was determined in hippocampal lysates using anti-phospho-S408/409-b3 subunit antibody (1:500; Symansis, Temecula, CA) and anti-phospho-S327-c2 subunit antibody (1:500; Abcam, Cambridge, MA). The membranes were blocked in 5% bovine serum albumin in Tris-buffered saline with Tween during the Western blotting procedure.
Electrophysiological Studies
Action potential-independent synaptic GABAR-mediated currents (miniature inhibitory postsynaptic currents [mIPSCs]) were recorded from dentate granule cells (DGCs) as previously described. 10, 11 The experiments were conducted within 3 hours of brain slice preparation. All the recordings were performed at 30 8C. The mIPSCs were analyzed using MiniAnalysis software (Synaptosoft, Decatur, GA).
10,11
Statistical Analysis
Values are expressed as mean 6 standard error of mean. Data were analyzed using paired t test, Wilcoxon matched-pair signed-rank test, or analysis of variance (ANOVA) with post hoc Dunnett multiple comparison as warranted, and p < 0.05 was considered statistically significant.
Results
Benzodiazepine Pharmacoresistance Was Present during LiPilo-SE but Not KA-SE Development of benzodiazepine pharmacoresistance during LiPilo-SE in adult animals and animals as young as postnatal day 15 (P15) has been well established. 8, 11, 16, 17 We confirmed this finding in P23 to P25 animals in which seizures of 3 minutes (early SE) or 60 minutes (late SE) in duration were treated with diazepam ranging in dose from 3 to 30mg/kg. Seizure termination was operationally defined as the time at which the spiking pattern became nonperiodic and fell below 2Hz. 11 Successful treatment was defined as electrographic seizure termination within 30 minutes of diazepam administration without electrographic recurrence for an additional 90 minutes. Each EEG tracing was independently reviewed by 2 readers (K.M.H., H.P.G.). A kappa score of 0.90 for seizure termination was achieved. In those cases in which there was not concordance, both reviewers reached a mutual agreement. Sample EEG traces obtained from a hippocampal depth electrode from an animal treated with diazepam 10mg/kg at 3 minutes and at 60 minutes after seizure onset of LiPilo-induced seizures are displayed in Figure 1 . Thirty minutes after diazepam administration, the EEG demonstrates termination of the seizure treated at 3 minutes after onset, whereas the seizure treated 60 minutes after onset persisted, and a periodic pattern of spikes was still present 2 hours after treatment.
The diazepam dose response of animals that were seizure-free 30 minutes after treatment without recurrence for LiPilo-induced seizures is shown in Figure 1Ai . At each dose, 5 animals were treated at each of the 2 time points. Seizures 3 minutes in duration were successfully treated with a median effective dose of 6.5mg/kg. In contrast, the animals treated at the late time point were refractory to the diazepam even at a dose of 30mg/kg.
Previous studies have demonstrated that a similar pattern of benzodiazepine pharmacoresistance develops for SE induced via electrical stimulation, 18 whereas SE induced via the organophosphate paraoxon was responsive to diazepam 30 minutes after seizure onset. 19 To determine whether the etiology of SE can affect the response to treatment, the efficacy and potency of diazepam in terminating KA-induced seizures of 3 minutes and 60 minutes in duration were assessed. Sample EEG traces obtained from a hippocampal depth electrode from an animal treated with diazepam 10mg/kg at 3 minutes and at 60minutes after KAinduced seizure onset are displayed in Figure 1B . After a period of seizure suppression lasting for 20 minutes after diazepam administration, the KA-induced seizure treated at the early time point recurred prior to the 30-minute time point, whereas the KA-induced seizure treated 60 minutes after onset stopped prior to the 30-minute time point and did not recur over the next 90 minutes.
The diazepam dose response of animals that were seizure-free 30 minutes after treatment without recurrence for KA-induced seizures is shown in Figure 1Br . At each dose, 5 animals were treated at each of the 2 time points. Seizures 3 minutes in duration were difficult to treat, with an extrapolated median effective dose of 85mg/kg. Failures at the lower doses (3 and 5mg/kg) at the early time point resulted from failure to terminate seizure progression. However, at the higher doses (10, 20 , and 30mg/kg), after an initial period of suppression, the seizure recurred within the 90-minute time period.
In contrast, diazepam was more effective in terminating the seizures treated 60 minutes after onset without recurrence during the recording period and with better potency (median effective dose 5 10mg/kg).
It was previously noted that the effects of diazepam on SE are dependent on clinical and electrographic stage. 17, 20 In naive animals (n 5 5), the 8mg/kg dose of
KA resulted in seizures that lasted longer than 7 hours in all animals (Fig 2A) . To further define the differences in the progression of SE induced by LiPilo compared to KA, total power spectrum analysis was performed. For the LiPilo-SE (n 5 4), there was a rapid increase in total power that reached a maximum during the first 30 minutes and then remained essentially stable with only a minimal decline over the displayed 3-hour duration (see Fig 2B) . In contrast, total power for the KA-SE (n 5 9) did not reach a maximum as quickly and total power remained lower than that observed for LiPilo-SE (p < 0.001, Wilcoxon matched-pairs signed rank test).
Given this slower progression to a continuous electrographic seizure, the efficacy and potency of diazepam to terminate KA-SE of 180-minute duration was assessed. Sample EEG tracings obtained from a hippocampal depth electrode from a single animal successfully treated with diazepam 10mg/kg at 180 minutes after seizure onset are shown in Figure 2C . The diazepam dose response of animals that were seizure-free 30 minutes after treatment without recurrence for KA-SE of 180-minute duration is shown in Figure 2C . At each dose, 5 animals were treated. Diazepam efficacy was similar to that observed when treatment occurred 60 minutes after KA-SE onset, and there was only minimal shift in potency from 10mg/kg at 60 minutes after onset to 14mg/kg for the KA-SE treated at the 180-minute time point.
Surface Expression of the GABAR c2 Subunit Was Reduced after LiPilo-SE but Not KA-SE The development of benzodiazepine pharmacoresistance during LiPilo-SE has been associated with a reduced surface expression of the benzodiazepine-sensitive c2 subunit-containing synaptic GABARs. 10, 12, 13 If this modification in the postsynaptic GABAR pool contributes to benzodiazepine pharmacoresistance, then the surface expression of the c2 subunit would be expected to be preserved during KA-SE.
The surface expression of the c2 subunit was assessed using a biotinylation assay in whole hippocampal slices acutely obtained after 60 minutes of LiPilo-SE, 60 minutes of KA-SE, and 180 minutes of KA-SE. Control animals and SE-treated animals were run in parallel. All hippocampal slices from an individual animal were pooled.
Representative Western blots demonstrating the decrease in the c2 subunit surface expression following LiPilo-SE compared to the control are displayed in Figure 3A . The total c2 subunit expression in the LiPilo-SE samples was comparable to control. The expression of the c2 subunit was quantified using scanning densitometry. For the total population of control (n 5 6) and The surface expression of the c2 subunit presented as mean 6 SEM of the ratio of the surfaceto-total expression in control slices and KA-induced SE-treated slices obtained either 1 hour or 3 hours after seizure onset (n 5 5 at 1 hour after KA-induced SE and n 5 6 at 3 hours after KA-induced SE). (E) Sample Western blots of the surface protein fraction and total protein fraction (Input) of the GABAR c2 subunit in hippocampal slices acutely obtained from P23 to P25 control animals or lithium-pretreated animals that received diazepam (DZP; 10mg/kg) 10 minutes prior to the injection of pilocarpine. The slices were obtained 90 minutes after the administration of the pilocarpine. The purity of surface proteins was checked in each assay by confirming the absence of b-actin expression in the surface protein fraction. (F) The surface expression of the c2 subunit presented as mean 6 SEM of the ratio of the surface-to-total expression in control slices and DZP slices (n 5 5). (G) Averaged miniature inhibitory postsynaptic current (mIPSC) traces from a control (black) dentate granule cell (DGC) and a KA-induced SE-treated (red) DGC voltage clamped to a holding potential of 260mV. The median amplitude for the mIPSCs recorded from the control neuron displayed here was 34pA (black tracing) and that for the KA-induced SE-treated neurons displayed here was 31pA (red tracing). (H) A bar graph displaying the mean of the median mIPSC amplitude for the population of control and KA-induced SE-treated DGCs (n 5 8 neurons from 4 control animals and n 5 8 neurons from 5 SE animals).
LiPilo-SE animals (n 5 6), the surface-to-total ratios were 0.64 6 0.07 and 0.30 6 0.06, respectively (p < 0.005). Therefore, the normalized surface expression of the c2 subunit in the LiPilo-SE animals was 47 6 7% of that in controls (see Fig 3B) .
In contrast to the LiPilo-SE animals, the surface expression of the c2 subunit in the acutely obtained hippocampal slices from KA-SE animals was not altered. For the total population of control (n 5 5) and KA-SE animals (n 5 5), the surface-to-total ratios were 0.52 6 0.05 and 0.41 6 0.08, respectively (p > 0.05). Thus, the normalized surface expression of the c2 subunit in the KA-SE animals was 83 6 18% of that in controls (see Fig 3D) . The surface and total expression of the c2 subunit was also measured in hippocampal slices acutely obtained after KA-SE of 3-hour duration. For the total population of 5 KA-SE animals, the surface-to-total ratio was 0.48 6 0.07 (100 6 24% of controls, n 5 6, p > 0.05; see Fig 3D) . Thus, even 3 hours after onset, the surface expression of the GABAR c2 subunit was not decreased.
The change in the c2 subunit surface expression was previously correlated with a decrease in the postsynaptic response to the presynaptic release of GABA. 10, 12, 13 Receptor internalization requires lateral movement of the receptor out of the synapse prior to internalization. 22 The finding that c2 subunit surface expression was not reduced during KA-SE does not exclude the possibility that receptors had moved out of the synapse to an extrasynaptic location but had not been internalized. To investigate this possibility, mIPSCs were recorded from DGCs in hippocampal slices acutely obtained after 3 hours of KA-SE and the mIPSC amplitude was compared to that recorded from DGCs in hippocampal slices obtained from control animals. Representative "averaged" mIPSCs for a control neuron and KA-SE-treated neuron are shown in Figure 3G . For a population of 8 control neurons (4 animals) and 8 KA-SE-treated neurons (5 animals), the mIPSC amplitudes were similar, 34.2 6 2.4pA and 31.5 6 3.8pA, respectively (p > 0.05; see Fig 3H) . For the control and KA-SE-treated neuron populations, the charge transfer was also similar (940.2 6 203.6pC vs 828.4 6 143.9pC, p > 0.05). This complementary experiment demonstrates that the GABAR population present at the synapse was preserved during KA-SE.
These findings raised the possibility that the altered GABAR surface expression may be a direct, seizureindependent effect of lithium and pilocarpine. To address this possibility, the c2 subunit surface expression was compared in control animals and LiPilo-treated animals that received a single dose of diazepam (10mg/kg) 10 minutes before the injection of pilocarpine. These animals did not develop seizures (data not shown). The hippocampal slices were acutely obtained 90 minutes after pilocarpine injection, the approximate duration after pilocarpine injection for the experiments using the LiPilo-SE animals. Representative Western blots displaying the surface and total expression for a control animal and LiPilo-treated animal in which the seizure was prevented by diazepam are displayed in Figure 3E . For the total population of control (n 5 5) animals and diazepam-treated animals (n 5 5), the surface-to-total expression ratios were 0.54 6 0.09 and 0.72 6 0.2, respectively. Therefore, as shown in Figure 3F , the normalized c2 subunit surface expression was similar to that of the control animals (p > 0.05). Therefore, the change in the c2 subunit surface expression was most likely in response to the seizure and not a direct effect of the lithium and pilocarpine.
Changes in the Surface Expression of the Kv4.2 Potassium Channel during SE Are Also ModelDependent The findings above demonstrate that activity-dependent GABAR trafficking during SE is, in part, dependent on etiology. A prior study demonstrated a decrease in the surface expression of Kv4.2 after KA-SE. 23 To determine whether there was a similar etiological influence on the surface expression of these channels during SE, Kv4.2 surface expression was measured in hippocampal slices acutely obtained from animals after 1 hour of LiPilo-SE and after 3 hours of KA-SE and compared to the surface expression of these channels in hippocampal slices obtained from controls. Representative Western blots for the surface and total expression of Kv4.2 demonstrating an increase in the surface expression of Kv4.2 after LiPilo-SE and a decrease after KA-SE compared to a control are displayed in Figure 4A . The total expression of Kv4.2 was similar for the control and SE-treated animals. Kv4.2 expression was quantified using scanning densitometry. For the total population of control (n 5 6), LiPilo-SE (n 5 6), and KA-SE (n 5 6) animals, the surface-to-total Kv4.2 expression ratios were 0.42 6 0.06, 0.60 6 0.08, and 0.27 6 0.04, respectively. The normalized Kv4.2 expression after LiPilo-SE was 143 6 20% of controls (p < 0.05), and the normalized Kv4.2 expression after KA-SE was 67 6 10% that of controls (p < 0.05; see Fig  4B) . Thus, the surface expression of Kv4.2 was also differentially regulated in LiPilo-SE and KA-SE.
Phosphorylation-Dependent Regulation of GABARs during SE Is Site-Specific
The b3 and c2 GABAR subunits contain putative AP2 binding sites, which when dephosphorylated can interact with the AP2 domain of clathrin leading to receptor internalization. 24 A prior study 13 demonstrated that the b3 site is dephosphorylated during Pilo-SE. Other studies have demonstrated that phosphatase inhibition can block activity-dependent GABAR trafficking during SE. 11, 25 What is not known is whether the dephosphorylation of the b subunit during SE resulted from a promiscuous process that leads to dephosphorylation of all the receptor's phosphorylation sites or a site-directed process that leads to posttranslational changes at a limited number of phosphorylation sites. To confirm and extend that prior finding, 13 the phosphorylation of the b3 (S408/409) and c2 (S327) subunits was determined after LiPilo-SE of 1-hour duration and KA-SE of 3-hour duration.
A comparison of SE-induced changes in the expression of pS408/409b3 and pS327c2 in hippocampal slices acutely obtained in animals in LiPilo-SE and KA-SE is displayed in Figure 5 . As with a prior study, 13 there was a reduction in the phosphorylated fraction of the b3 GABAR subunit in hippocampal proteins obtained from LiPilo-SE animals. For 6 experimental replicates, the pS408/409b3-to-total-b3 expression following LiPilo-SE was only 39 6 3% of the expression seen in control animals (n 5 7, p < 0.05; see Fig 5A, B) .
To address the question of site-specificity of posttranslational modifications during SE, the ratio of the c2 subunit phosphorylated at S327 to the total c2 fraction following 1 hour of LiPilo-SE was compared to controls. Across 7 experimental replicates, the ratio of the pS327c2-to-total-c2 expression in the LiPilo-SE animals was 131 6 19% of that in controls (p > 0.05; see Fig 5A,  C) . This result suggests that posttranslational modifications of the GABAR population is not the result a nonspecific process but of a site-specific process that targets only a subset of the receptor's phosphorylation sites.
In contrast to these results obtained following 1 hour of LiPilo-SE, the phosphorylated fraction of both the b3 and the c2 subunit in whole hippocampal slices obtained from KA-SE animals was unchanged. For 7 experimental replicates, the pS408/409b3-to-total-b3 expression was also similar to control (83 6 13% of control, n 5 7, p > 0.05, ANOVA; see Fig 5A, B) . For 5 experimental replicates, the pS327c2-to-total-c2 ratio was 115 6 17% that of controls (p > 0.05; see Fig 5A, C) . These findings are concordant with the absence of a change in the GABAR surface expression after 3 hours of KA-SE.
Discussion
The novel findings of this study are (1) diazepam remained a potent and effective agent for terminating KA-SE of 1-and 3-hour duration, (2) the surface expression of the benzodiazepine-sensitive c2 subunit and GABA-mediated synaptic inhibition were not reduced as a result of KA-SE, and (3) the change in the surface expression of the Kv4.2 potassium channel was differentially regulated during LiPilo-SE and KA-SE.
This study confirms previous findings of reduced potency of diazepam in terminating late LiPilo-SE with an associated decrease in the surface expression of the benzodiazepine-sensitive c2 subunit-containing GABARs resulting from a dephosphorylation of a b subunit. 8, 10, 11, 13, 16 It extends those findings by demonstrating that the receptor's posttranslational modification, which is permissive for the receptor's internalization, results from a site-directed process and not the indiscriminate removal of all phosphate groups on all subunits.
Preserved GABA-Mediated Synaptic Inhibition during KA-SE Successful seizure termination in this study was defined as the seizure stopping within 30 minutes without recurrence for an additional 90 minutes. This criterion was based on diazepam's pharmacokinetic properties that result in this medication's redistribution leading to a lowering of its initial high brain concentration such that it has a shorter duration of action and there is potential for seizure recurrence. 26, 27 Based on this criterion, the prolonged 1-and 3-hour KA-induced seizures were responsive to diazepam and benzodiazepine pharmacoresistance was not observed. This finding combined with the preserved surface expression of the benzodiazepine-sensitive c2 subunit-containing GABARs and preserved postsynaptic response to GABA demonstrated that the postsynaptic GABA-mediated synaptic apparatus was maintained during KA-SE.
The potential that the prolonged KA-induced seizures recurred after the EEG recording session was completed cannot be excluded. Recurrence of seizures after successful termination has been reported for both short and long KA-induced seizure durations, 27 was the primary reason in our study for failed termination after early treatment of KA-induced seizures, and may be the reason that one study 28 in which recording after diazepam was performed for up to 48 hours concluded that benzodiazepine pharmacoresistance was not dependent on etiology.
Distinct Pattern of Seizure Evolution between
LiPilo-SE and KA-SE In comparison to LiPilo-SE, a slower progression of KA-SE through the electrographic SE stages was observed. Furthermore, analysis of EEG power during the LiPilo-SE and KA-SE demonstrated clear differences in seizure progression, suggesting etiology may influence neuronal activation patterns, which may have a subsequent effect on which and the frequency with which certain neurotransmitters are released and which second messenger systems are activated. These differences may not only influence the response to treatment observed in this study but could also account for the well-described difference in functional , GABAR b3 subunit, phosphorylated GABAR c2 subunit (S327), and GABAR c2 subunit in whole hippocampal slices acutely obtained from control animals (C), animals in status epilepticus of 1-hour duration induced by LiPilo, and animals in status epilepticus of 3-hour duration induced by KA. In the representative blot shown in this figure, the pS408/ 409b3 to total b3 expression in the LiPilo-induced SE animals was 0.03 compared to 0.13 for the control. (B) Phosphorylated GABAR b3 subunit expression normalized to total GABAR b3 subunit expression presented as mean 6 standard error of mean (SEM) in hippocampal slices obtained from control animals, LiPiloinduced SE-treated animals, and KA-induced SE-treated animals (n 5 7 each for pb3, n 5 7 for pc2 LiPilo, and n 5 5 for pc2 KA, *p < 0.05). (C) Phosphorylated GABAR c2 subunit normalized to total GABAR c2 subunit expression presented as mean 6 SEM in whole hippocampal slices obtained from control animals, LiPiloinduced SE-treated animals, and KA-induced SE-treated animals. The reactivity of the pS408/409b3 and pS327c2 antibodies for the phosphorylated forms of the subunits was confirmed using brain tissue lysates treated with k-phosphatase (1 lg/100 lg protein) for 30 minutes at 37 8C. Treatment with k-phosphatase reduced the phosphorylated form of the GABAR subunit; the immunoreactivity of pS04/409b3 and pS327c2 antibodies in the k-phosphatase-treated lysates was lower than that in the untreated lysates. For 3 experimental replicates, the pS408/ 409b3 expression in the k-phosphatase-treated lysate was 28 6 8.5% of that in the untreated lysate, and pS327c2 expression in the k-phosphatase-treated lysate was 39 6 12% of that in the untreated lysates (p < 0.05; data not shown).
anatomy and histopathological outcome observed following SE in these 2 animal models. 29, 30 To ensure that the changes in the surface expression of the c2 subunit-containing GABARs was not a direct pharmacological effect of the lithium and pilocarpine, the receptor surface expression was measured in hippocampal slices acutely obtained from LiPilo-treated animals in which the seizure was prevented by the administration of diazepam prior to the pilocarpine. In this situation, in the absence of the seizure, a change in the surface expression was not observed. This finding in combination with similar experiments performed by Wasterlain and colleagues 12 provides additional evidence for neuronal activity-dependent modulation of GABAR trafficking during seizures. The extracellular glutamate concentration and the extent of calcium influx can lead to differential signaling and surface membrane stability of GABARs. For example, brief application of N-methyl-D-aspartate (NMDA) increases GABAR surface expression in cultured hippocampal neurons, whereas a brief application of glutamate reduced GABAR surface expression. 31, 32 These differences were attributed to differences in the association of CaMKII with GABARs. Furthermore, a sustained calcium influx through NMDA receptor activation is proposed to activate calcineurin, leading to destabilization of surface GABARs. In contrast, a moderate increase in glutamate, which can activate metabotrophic glutamate receptors, stabilizes surface GABARs. 33 Future studies will be required to determine whether the model-dependent differences that were observed in the phosphorylation and surface expression of GABARs in these 2 models are the result of differences in excitatory amino acid release, differences in the excitatory amino acid receptors activated, or differences in calcium influx that occurred during the SE induced by LiPilo versus KA.
Internalization of GABARs and Dephosphorylation of Specific Residues
Posttranslational modifications such as phosphorylation and dephosphorylation of serine/threonine residues on a1, b2/3, a4, and c2 subunits are critical in regulating the pool of functional GABARs present on the cell surface under pathophysiological conditions. 34 Phosphorylation of S408/409 residues on the b2/3 subunits by protein kinase C and CaMKII increases the GABAR surface expression, whereas dephosphorylation of these residues by protein phosphatases increases the interaction of GABARs with the AP2 domain of clathrin-endocytic machinery, leading to receptor internalization. 13, 24 A dephosphorylation of b3 S408/409 residues in adult mice in SE was associated with reduced GABAR surface expression. 13 In a prior study, blockade of protein phosphatases was efficacious in preventing or recovering the reduced expression of functional GABARs during in vivo or in vitro SE. 11 The observed dephosphorylation of the b3 subunit in the hippocampi of LiPilo-SE animals but not in KA-SE animals points to a phosphorylationdependent mechanism underlying the differential changes in the surface expression of GABARs seen in the 2 models of SE employed in this study. In contrast to dephosphorylation of b3 subunits in the hippocampi of LiPilo-SE animals, the phosphorylation of c2 subunits on S327 remained unaltered in both models of SE. The c2 subunit S327 is a target of calcineurin, which is activated during SE. 35, 36 These findings suggest that protein phosphatase activation does not trigger a general dephosphorylation of different proteins. The mechanisms that protect phosphorylated residues on the c2 subunit are currently unknown. In neurotransmitter receptors assembled from heteromeric subunit combinations, one of the subunits often plays a dominant role in regulating the surface membrane trafficking 37, 38 ; it appears that the dephosphorylation of b3 subunits plays a prominent role in the internalization of GABARs in SE irrespective of posttranslational modification of other subunits.
Model-Specific Changes in the Expression of Kv4.2 Channels
Rapidly activating K 1 current (A-type current) mediated by a voltage-gated potassium channel such as Kv4.2 regulates neuronal activity. The surface expression of Kv4.2 channels was also differentially regulated in LiPilo-SE and KA-SE animals; it was reduced in KA-SE animals as has been reported before 23 but increased in LiPilo-SE animals.
Whether this upregulation follows a similar time course as that of the reduction in GABAR-mediated inhibition, which occurs as early as 15 minutes after the onset of SE, 39 is not known. But it could compensate for the reduced GABAR-mediated inhibition. Phosphorylation of Kv4.2 channels by ERK1/2 mitogen-activated protein kinases, which are activated during SE, 40, 41 reduces channel surface expression. 23 The activation of protein phosphatases during SE may also play a role in dephosphorylation and increased surface expression of Kv4.2 channels during LiPilo-SE. Taken together, these findings show etiology-dependent differences in the regulation of GABARs and KV4.2 channel.
Clinical Implications
Although triggered by chemoconvulsants, LiPilo-SE and KA-SE share commonalities with SE in the human including changes in cerebral blood flow, breakdown of the blood-brain barrier, cerebral edema, neuronal injury, and the later development of recurrent, unprovoked seizures and cognitive deficits. [42] [43] [44] [45] [46] [47] [48] Therefore, studies of SE in these models allows for an approximation of the molecular and cellular mechanisms that may occur during SE in the human. Certainly, studies that serve to confirm and extend these findings will seek additional SE models in which SE is triggered by etiologies that more commonly occur in the human. Independent of etiology, all prolonged seizures of SE are self-sustaining and share a low probability of spontaneous seizure termination. 49 Our findings of model-dependent differences in the response to diazepam, activity-dependent trafficking, and synaptic inhibition provide additional support for the hypothesis that a modification in the postsynaptic GABAR population contributes to the development of benzodiazepine pharmacoresistance. These findings also support a novel hypothesis that the molecular changes that occur during SE, changes that may impact response to treatment, are also dependent on etiology. A mechanism that depends on both etiology and duration may explain why some seizures remain responsive to benzodiazepines and other agents-even at the most prolonged durations such as in the Veterans Affairs Status Epilepticus Cooperative Study, in which 10 to 30% of patients in the subtle SE group responded to treatment-and why some etiologies are more likely to result in SE episodes that are resistant to treatment. 3 Until the role of etiology in determining response is further defined with the potential future development of etiology-dependent protocols, 50 these results support current SE treatment protocols in which a 1,4-benzodiazepine is recommended as the first-line treatment independent of seizure duration and etiology.
